Predict your next investment

WavoDyne Therapeutics company logo
HEALTHCARE | Biotechnology
wavodyne.com

See what CB Insights has to offer

Founded Year

2015

Stage

Unattributed | Alive

Total Raised

$3.45M

Last Raised

$50K | 6 yrs ago

About WavoDyne Therapeutics

WavoDyne Therapeutics commercializes a group of small molecule therapeutics which have displayed potency in preclinical models for the treatment of memory and cognitive disorders resulting from neuroinflammatory processes.

WavoDyne Therapeutics Headquarter Location

150 Lucius Gordon Drive Suite 100

West Henrietta, New York, 14586,

United States

954-632-6630

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing WavoDyne Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

WavoDyne Therapeutics is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.